期刊文献+

多发性硬化20例临床特点分析 被引量:1

原文传递
导出
摘要 目的总结多发性硬化(MS)患者的临床特点。方法采用回顾性调查的临床病例分析统计方法,对20例MS患者的起病和临床表现进行归纳、分析。结果 MS好发于青壮年,女性,以急性和亚急性起病为主,首发症状以视力障碍(45%)最常见,其次为肢体无力(20%),感觉障碍(10%)。结论国内MS的发病,起病急,病程短,视神经及脊髓易受侵犯,小脑脑干较少受累,临床表现中以视神经受损及肢体无力为主。急性,亚急性期应用激素疗效显著。
作者 张建强
出处 《中国煤炭工业医学杂志》 2012年第4期505-506,共2页 Chinese Journal of Coal Industry Medicine
  • 相关文献

参考文献5

二级参考文献21

  • 1Poser CM,Paty DM, Scheinbery L, et al. New diagnostic criteria for multiplesclerosis, guidelines for research protocols [J]. Ann Neural,1983,13(3) :227.
  • 2Clanet M,Radue EW,Kappos L,et al.A randomized,double-blind,dose-comparison study of weekly interferon beta-1a in relapsing MS[J].Neurology,2002,59(10):1 507-1 517.
  • 3PRISMS(Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis)Study Group.Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis[J].Lancet,1998,352(9 139):1 498-1 504.
  • 4Panitch H,Goodin DS,Francis G,et al.Randomized,comparative study of interferon beta-1a treatment regimens in MS:The EVIDENCE Trial[J].Neurology,2002,59(10):1 496-1 506.
  • 5Li DK,Zhao GJ,Paty DW,et al.Randomized controlled trial of interferon-beta-1a in secondary progressive MS:MRI results[J].Neurology,2001,56(11):1 505-1 513.
  • 6European study group on interferon β-1b in secondary progressive MS.Placebo-controlled multicentre randomized trial of interferon β-1b in treatment of secondary progressive multiple sclerosis[J].Lancet,1998,352(9 139):1 491-1 497.
  • 7Leary SM,Miller DH,Stevenson VL,et al.Interferon beta-1a in primary progressive MS:an exploratory,randomized,controlled trial[J].Neurology,2003,60(1):44-51.
  • 8Rudick RA,Simonian NA,Alam JA,et al.Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis[J].Neurology,1998,50(5):1 266-1 272.
  • 9Flechter S,Vardi J,Pollak L,et al.Comparison of glatiramer acetate (Copaxone) and interferon beta-1b (Betaferon) in multiple sclerosis patients:an open-label 2-year follow-up[J].J Neurol Sci,2002,197(1-2):51-55.
  • 10Khan OA,Tselis AC,Kamholz JA,et al.A prospective,open-label treatment trial to compare the effect of IFN beta-1a (Avonex),IFN beta-1b (Betaseron),and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis[J].Eur J Neurol,2001,8(2):141-148.

共引文献2

同被引文献9

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部